| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/20/2013 | EP2569294A1 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569293A1 Pyrazolopyridines as inhibitors of the kinase lrrk2 |
| 03/20/2013 | EP2569286A2 Compounds useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569285A1 Bifunctional quinoline derivatives |
| 03/20/2013 | EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/20/2013 | EP2568985A1 Polymorphs of alogliptin benzoate |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1302801B Substituted aminoquinazolone (thio-ketone) derivative or its salt, its intermediate and pest controlling agent and its application method |
| 03/20/2013 | CN102985417A Piperidin-4-yl azetidine derivatives as JAK1 inhibitors |
| 03/20/2013 | CN102985416A Process of preparing a thrombin specific inhibitor |
| 03/20/2013 | CN102985412A 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 03/20/2013 | CN102985411A Imaging agents for detecting neurological disorders |
| 03/20/2013 | CN102985407A 8-hydroxy-quinoline derivatives |
| 03/20/2013 | CN102977367A Preparation method of hindered amine light stabilizer (HALS) |
| 03/20/2013 | CN102977078A Preparation method of solid form neutral esomeprazole |
| 03/20/2013 | CN102977077A Method for preparing dabigatran etexilate intermediate |
| 03/20/2013 | CN102977076A Preparation method of dexlansoprazole |
| 03/20/2013 | CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 03/20/2013 | CN102977028A Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives |
| 03/20/2013 | CN102977016A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102977015A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102977006A Pyridine-fluorene organic electrophosphorescence main body luminescent material and preparation method thereof |
| 03/20/2013 | CN102329301B Esomeprazole sodium compound and preparation method thereof |
| 03/20/2013 | CN102234264B Synthesis method of N-[6-(8-benzyloxy quinolyl)-hexyl]carbazole |
| 03/20/2013 | CN101914090B Method for preparing levo-omeprazole |
| 03/20/2013 | CN101891673B Organic material and application thereof in organic electroluminescence devices |
| 03/20/2013 | CN101772486B Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 03/20/2013 | CN101735196B Method for synthesizing Imatinib |
| 03/20/2013 | CN101573338B Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 03/20/2013 | CN101508692B Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 03/20/2013 | CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 03/19/2013 | US8399679 Aryl-substituted pyrazoles |
| 03/19/2013 | US8399678 Process for the manufacture of dabigatran etexilate |
| 03/19/2013 | US8399673 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399666 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 03/19/2013 | US8399505 Sulfonylpyrroles |
| 03/19/2013 | US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
| 03/19/2013 | US8399491 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 03/19/2013 | US8399489 Antibacterial piperdine derivatives |
| 03/19/2013 | US8399488 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/19/2013 | US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/19/2013 | US8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| 03/19/2013 | US8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 03/19/2013 | US8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis |
| 03/19/2013 | US8399436 N-pyrazolyl carboxamides as CRAC channel inhibitors |
| 03/19/2013 | CA2569824C Phthalazine derivatives as parp inhibitors |
| 03/19/2013 | CA2549228C Hiv protease inhibiting compounds |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013035826A1 Fused heterocyclic compound |
| 03/14/2013 | WO2013035102A1 Processes for the preparation of imatinib base and intermediates thereof |
| 03/14/2013 | WO2013034506A1 Pde10 modulators |
| 03/14/2013 | WO2013034238A1 Benzonitrile derivatives as kinase inhibitors |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | US20130066114 Insecticide for agricultural or horticultural use and method of use thereof |
| 03/14/2013 | US20130066081 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof |
| 03/14/2013 | US20130066075 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065927 Forms of dexlansoprazole and processes for the preparation thereof |
| 03/14/2013 | US20130065925 Pyrrolidin-3-ylacetic acid derivative |
| 03/14/2013 | US20130065923 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065919 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065918 Soluble guanylate cyclase activators |
| 03/14/2013 | US20130065911 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 03/14/2013 | US20130065907 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 03/14/2013 | US20130065906 New compounds, pharmaceutical compositions and uses thereof |
| 03/14/2013 | US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
| 03/14/2013 | US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 03/14/2013 | US20130065896 Fused imidazole derivative |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065879 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065876 3-pyridine carboxylic acid hydrazides |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065757 Chemical compounds |
| 03/14/2013 | US20130064770 Radiolabeled compounds and methods thereof |
| 03/14/2013 | DE102011113749A1 Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole Sulfonic heterocyclylamide-substituiertr imidazoles |
| 03/14/2013 | CA2848148A1 Benzonitrile derivatives as kinase inhibitors |
| 03/14/2013 | CA2844652A1 Pde10 modulators |
| 03/13/2013 | EP2567954A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline |
| 03/13/2013 | EP2566860A1 Bicyclic heteroaryl compounds as gpr119 modulators |
| 03/13/2013 | EP2566859A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same |
| 03/13/2013 | EP2566858A2 Heterocyclic derivatives as alk inhibitors |
| 03/13/2013 | EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase |
| 03/13/2013 | EP2566849A1 8-hydroxy-quinoline derivatives |
| 03/13/2013 | EP2566477A1 Amino-quinolines as kinase inhibitors |
| 03/13/2013 | EP2566328A1 Indazoles |
| 03/13/2013 | CN1938244B Fluoridation method |
| 03/13/2013 | CN102971311A Bicyclic heteroaryl compounds as GPR119 modulators |
| 03/13/2013 | CN102971310A (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 03/13/2013 | CN102971309A Fungicide hydroximoyl-heterocycles derivatives |
| 03/13/2013 | CN102971308A Non-nucleoside reverse transcriptase inhibitors |
| 03/13/2013 | CN102971307A Piperidinyl pyrimidine amides as KV7 potassium channel openers |
| 03/13/2013 | CN102971306A Pyrazolopyridines as inhibitors of the kinase LRRK2 |
| 03/13/2013 | CN102971305A Heterocyclic antiviral compounds |
| 03/13/2013 | CN102971304A GPR119 agonist |
| 03/13/2013 | CN102971302A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 03/13/2013 | CN102971293A Bipyridyl derivatives useful for the treatment of kinase-induced diseases |